Search
Ketamine Treatment Options in Long Beach, CA
A collection of 2 research studies where Ketamine is the interventional treatment. These studies are located in the Long Beach, CA. Ketamine is used for conditions such as Pain, Major Depressive Disorder and Depression.
1 - 2 of 2
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
VA Aripiprazole vs Esketamine for Treatment Resistant Depression
Withdrawn
This is an open-label, parallel-group, randomized clinical trial of up to 6 months treatment of adjunctive intranasal (IN) esketamine (ESK) vs. adjunctive aripiprazole (ARI) in Veterans with unipolar Treatment Resistant Depression (TRD). This study will assess the efficacy, safety, and acceptability of adjunctive IN ESK in comparison to ARI, one of the best studied and most widely used adjunctive therapies for TRD. The primary hypothesis is that participants receiving adjunctive IN ESK will be s... Read More
Gender:
ALL
Ages:
Between 18 years and 74 years
Trial Updated:
01/03/2024
Locations: VA Long Beach Healthcare System, Long Beach, CA, Long Beach, California +2 locations
Conditions: Depressive Disorder, Major
A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
Completed
This study is a phase 1, double-blind, placebo-controlled crossover study of single, oral dose of SAGE-718 using a ketamine challenge, to evaluate the electrophysiology, safety, tolerability, and pharmacokinetics in healthy subjects
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
01/20/2022
Locations: Sage Investigational Site, Long Beach, California
Conditions: Healthy Volunteer
1 - 2 of 2